Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 22;16(1):6750.
doi: 10.1038/s41467-025-61937-1.

Specific oncogene activation of the cell of origin in mucosal melanoma

Affiliations

Specific oncogene activation of the cell of origin in mucosal melanoma

Swathy Babu et al. Nat Commun. .

Abstract

Mucosal melanoma (MM) is a deadly cancer derived from mucosal melanocytes. To test the consequences of MM genetics, we develop a zebrafish model in which all melanocytes experience CCND1 expression and loss of PTEN and TP53. Surprisingly, melanoma only develops from melanocytes lining internal organs, analogous to the location of patient MM. We find that zebrafish MMs have a unique chromatin landscape from cutaneous melanomas. Internal melanocytes are labeled using a MM-specific transcriptional enhancer. Normal zebrafish internal melanocytes share a gene expression signature with MMs. Patient and zebrafish MMs show increased migratory neural crest and decreased antigen presentation gene expression, consistent with the increased metastatic behavior and decreased immunotherapy sensitivity of MM. Our work suggests that the cell state of the originating melanocyte influences the behavior of derived melanomas. Our animal model phenotypically and transcriptionally mimics patient tumors, allowing this model to be used for MM therapeutic discovery. As this is a non-MAPK driven genetically engineered model of melanoma, our work also has implications for the 15% of cutaneous melanoma patients who lack MAPK-driving mutations.

PubMed Disclaimer

Conflict of interest statement

Competing interests: L.I.Z. is a founder and stockholder of Fate Therapeutics, CAMP4 Therapeutics, and Scholar Rock. He is a consultant for Celularity. B.J.A. is a shareholder in Syros Pharmaceuticals. E.I.B. serves as a consultant/advisory board member for Obsidian, Zola, Anaveon, Merck and Werewolf pharmaceuticals. G.M.B. has sponsored research agreements through her institution with: Olink Proteomics, Teiko Bio, InterVenn Biosciences, Palleon Pharmaceuticals, Astellas, and AstraZeneca. She served on advisory boards for: Iovance, Merck, Moderna, Nektar Therapeutics, Novartis, Replimune, and Ankyra Therapeutics. She consults for: Merck, InterVenn Biosciences, Iovance, and Ankyra Therapeutics. She holds equity in Ankyra Therapeutics. The remaining authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Zebrafish model recapitulates localization of human MM.
A Light micrographs of zebrafish melanoma generated from melanocyte-specific expression or CRISPR-deletion in transparent “Casper” zebrafish. Cutaneous model (upper). Mucosal model (lower). B MM free survival of zebrafish with melanocyte-specific expression of human CCND1 and melanocyte-specific CRISPR-deletion of pten a and b and tp53. CG Zebrafish melanoma histology. CM n = 4, MM n = 5. C, D H&E stain of MM (C) and CM (D). E, F Phospho ERK (pERK) immunohistochemistry (IHC) of MM (E) and CM (F). Scale bar = 1 mm; inset scale bar = 100 μm. Black arrow = tumor, red arrow = brain. G Quantification of % pERK positive zebrafish melanomas. H % zebrafish MM penetrance. n = zebrafish.
Fig. 2
Fig. 2. Zebrafish MM has a distinct cellular state from CM.
Volcano plots derived from DESeq2 of A bulk RNA-seq from zebrafish MM (n = 5) vs. CM (n = 3) and B ATAC-seq from zebrafish MM (n = 3) vs. CM (n = 3). C IGV plot of ATAC-seq showing chromatin accessibility at tfap2a and tfap2b in zebrafish MM vs. CM. Boxes = loci used for tfap2b reporter. D, E tfap2b enhancer driving GFP preferentially labels internal mitfa-mCherry labeled melanocytes in 6-day old Casper zebrafish. n = 6 zebrafish. D Fluorescent images. Scale bar = 500 μm. E Reporter expression quantification. *** =  0.0003, 2-way ANOVA with multiple comparisons. Mean ± SD. Source data are provided in Source Data Fig. 2E.
Fig. 3
Fig. 3. Zebrafish internal melanocytes have properties consistent with MM initiating cells.
A Light micrographs demonstrating internal GFP-expressing melanocytes from adult Casper zebrafish. Scale bar = 500 μm. n = 7 zebrafish. B Schematic for single-cell RNA-seq (scRNA-seq) of cutaneous and internal adult zebrafish melanocytes. Cutaneous melanocytes were combined from two zebrafish and mucosal melanocytes were combined from seven zebrafish. Created in BioRender. Insco, M. (2025) https://BioRender.com/da5ul5n. C UMAP of scRNA-seq from GFP-sorted external and internal melanocytes. D mitfa-expressing cells from (C). E UMAP of sub-clustered mitfa+ melanocytes. Blue = from internal. Red = from cutaneous. F tfap2a and tfap2b expression in “internal”, “external”, and “both” melanocyte groups from (E). G Dot plot showing gene expression of top differentially expressed genes from zebrafish MMs for Seurat-defined melanocyte clusters from Fig. S3D.
Fig. 4
Fig. 4. MM cell state is conserved in patients.
A UMAP of scRNA-seq from CM patients (n = 23) and MM patients (n = 10). B, C Normalized pseudobulked gene expression in CM vs. MM cells from scRNA-seq for B MAPK target genes, ** = 0.0036, two-sided t-test, and C HLA Class I antigen presentation genes, * = 0.017, two-sided t-test. Dots = patients. D Average gene expression of expressed zebrafish mhc class I/II genes in zebrafish CM vs. MM. Dots = genes. Lines indicate the same gene in both conditions. ** = 0.0017, Wilcoxon matched-pairs rank test. FPKM =  fragments per kilobase of transcript per million. E Normalized pseudobulked gene expression in MM vs. CM cells from scRNA-seq for migratory neural crest genes. * = 0.036, two-sided t-test. F Average gene expression (FPKM) of migratory neural crest genes in zebrafish CMs vs. MMs. Dots = genes. Lines indicate the same gene in both conditions. * = 0.031, Wilcoxon matched-pairs rank test. G, H Melanocyte-specific expression of hPAX3 (n = 10) vs. control (n = 12) in Casper zebrafish with labeled internal melanocytes (double positive mitfa-mCherry and tfap2b-GFP) and pigment removal at 6 dpf. G Representative immunofluorescent images. Scale bar = 500 μm. H Quantification of double positive melanocytes inside and outside zebrafish embryos. ** = 0.0014, ns = 0.7813, ordinary one-way ANOVA with multiple comparisons. I, J hPAX3-vs. empty control-expressing zebrafish MM (CCND1; pten a/b gRNA, tp53 gRNA). I Representative images at 23 weeks post-fertilization and J Tumor area quantification (* = 0.048, two-sided t-test). n = tumors. For all box plots, the box is the 25th to 75th percentile range and whiskers show maximum to minimum. For plots (B, C, E) the middle line represents the median. Source data are provided in Source Data Fig. 4.

Update of

References

    1. Altieri, L., Eguchi, M., Peng, D. H. & Cockburn, M. Predictors of mucosal melanoma survival in a population-based setting. J. Am. Acad. Dermatol81, 136–142.e132 (2019). - PMC - PubMed
    1. Newell, F. et al. Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets. Nat. Commun.10, 3163 (2019). - PMC - PubMed
    1. Curtin, J. A. et al. Distinct sets of genetic alterations in melanoma. N. Engl. J. Med.353, 2135–2147 (2005). - PubMed
    1. Hayward, N. K. et al. Whole-genome landscapes of major melanoma subtypes. Nature545, 175–180 (2017). - PubMed
    1. Ablain, J. et al. Human tumor genomics and zebrafish modeling identify SPRED1 loss as a driver of mucosal melanoma. Science362, 1055–1060 (2018). - PMC - PubMed

MeSH terms

LinkOut - more resources